Surgical management of colorectal cancer: A review of the literature

Indian Journal of Surgery

Volumn 71, Issue 6, 2009, Pages 350-355

  Chokshi, Ravi J ^a   Abdel Misih, S ^a   Bloomston, Mark ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Bowel preparations; Colorectal cancer; Minimally invasive colectomy; Stent

Indexed keywords

EID: 74849088268     PISSN: 09722068     EISSN: 09739793     Source Type: Journal    
DOI: 10.1007/s12262-009-0093-5     Document Type: Review

References (37)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
2. Guillem JG, Smith AJ, Calle JP, Ruo L (1999) Gastrointestinal polyposis syndromes. Curr Probl Surg 36: 217-323.
3. Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, Booker SV, Robinson CR, Offerhaus GJ (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328: 1313-1316.
4. Lynch HT, de la Chapelle A (2003) Hereditary colorectal cancer. N Engl J Med 348: 919-932.
5. Debinski HS, Love S, Spigelman AD, Phillips RK (1996) Colorectal polyp counts and cancer risk in familial adenomatous polyposis. Gastroenterology 110: 1028-1030.
6. Church J, Simmang C (2003) Practice parameters for the treatment of patients with dominantly inherited colorectal cancer (familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer). Dis Colon Rectum 46: 1001-1012.
7. Bertario L, Russo A, Radice P, Varesco L, Eboli M, Spinelli P, Reyna A, Sala P (2000) Genotype and phenotype factors as determinants for rectal stump cancer in patients with familial adenomatous polyposis. Hereditary Colorectal Tumors Registry. Ann Surg 231: 538-543.
8. Vasen HF, Watson P, Mecklin JP, Lynch HT (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116: 1453-1456.
9. Vasen HF, Mecklin JP, Khan PM, Lynch HT (1991) The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 34: 424-425.
10. Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M, Jarvinen HJ (1995) Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 64: 430-433.
11. Lynch HT, Riley BD, Weissman SM, Coronel SM, Kinarsky Y, Lynch JF, Shaw TG, Rubinstein WS (2004) Hereditary nonpolyposis colorectal carcinoma (HNPCC) and HNPCClike families: Problems in diagnosis, surveillance, and management. Cancer 100: 53-64.
12. Lynch HT (1996) Is there a role for prophylactic subtotal colectomy among hereditary nonpolyposis colorectal cancer germline mutation carriers? Dis Colon Rectum 39: 109-110.
13. Nichols RL, Broido P, Condon RE, Gorbach SL, Nyhus LM (1973) Effect of preoperative neomycin-erythromycin intestinal preparation on the incidence of infectious complications following colon surgery. Ann Surg 178: 453-462.
14. Slim K, Vicaut E, Panis Y, Chipponi J (2004) Meta-analysis of randomised clinical trials of colorectal surgery with or without mechanical bowel preparation. Br J Surg 91: 1125-1130.
15. Slim K, Vicaut E, Launay-Savary MV, Contant C, Chipponi J (2009) Updated systematic review and meta-analysis of randomised clinical trials on the role of mechanical bowel preparation before colorectal surgery. Ann Surg 249: 203-209.
16. Campisi P, Badhwar V, Morin S, Trudel JL (1999) Postoperative hypocalcemic tetany caused by fleet phosphosoda preparation in a patient taking alendronate sodium: report of a case. Dis Colon Rectum 42: 1499-1501.
17. Bergeron E, Ouellette D, Dube S, Beauchamp G (1997) Bowel preparation with polyethylene glycol electrolyte lavage solution is potentially hazardous in patients with carcinoma of the cardia: a case report. Can J Surg 40: 456-458.
18. Schelling JR (2000) Fatal hypermagnesemia. Clin Nephrol 53: 61-65.
19. The clinical outcomes of surgical therapy study group (2004) A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 350: 2050-2059.
20. Buunen M, Veldkamp R, Hop WC, Kuhry E, Jeekel J, Haglind E, Pahlman L, Cuesta MA, Msika S, Morino M, Lacy A, Bonjer HJ (2009) Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol 10: 44-52.
21. Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AM, Heath RM, Brown JM (2005) Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 365: 1718-1726.
22. Konyalian VR, Rosing DK, Haukoos JS, Dixon MR, Sinow R, Bhaheetharan S, Stamos MJ, Kumar RR (2007) The role of primary tumour resection in patients with stage IV colorectal cancer. Colorectal Dis 9: 430-437.
23. Cook AD, Single R, McCahill LE (2005) Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol 12: 637-645.
24. Damjanov N, Weiss J, Haller DG (2009) Resection of the primary colorectal cancer is not necessary in nonobstructed patients with metastatic disease. Oncologist 14: 963-969.
25. Scoggins CR, Meszoely IM, Blanke CD, Beauchamp RD, Leach SD (1999) Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol 6: 651-657.
26. Mentha G, Majno PE, Andres A, Rubbia-Brandt L, Morel P, Roth AD (2006) Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Br J Surg 93: 872-878.
27. Poultsides GA, Servais EL, Saltz LB, Patil S, Kemeny NE, Guillem JG, Weiser M, Temple LK, Wong WD, Paty PB (2009) Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol 27: 3379-3384.
28. Verhoef C, van der Pool AE, Nuyttens JJ, Planting AS, Eggermont AM, de Wilt JH (2009) The "liver-first approach" for patients with locally advanced rectal cancer and synchronous liver metastases. Dis Colon Rectum 52: 23-30.
29. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230: 309-318; discussion 318-321.
30. Ohman U (1982) Prognosis in patients with obstructing colorectal carcinoma. Am J Surg 143: 742-747.
31. Dohmoto M (1991) New method - Endoscopic implantation of rectal stent in palliative treatment of malignant stenosis. Endosc Digest 3: 1507-1512.
32. Tilney HS, Lovegrove RE, Purkayastha S, Sains PS, Weston-Petrides GK, Darzi AW, Tekkis PP, Heriot AG (2007) Comparison of colonic stenting and open surgery for malignant large bowel obstruction. Surg Endosc 21: 225-233.
33. Khot UP, Lang AW, Murali K, Parker MC (2002) Systematic review of the efficacy and safety of colorectal stents. Br J Surg 89: 1096-1102.
34. Saida Y, Sumiyama Y, Nagao J, Uramatsu M (2003) Longterm prognosis of preoperative "bridge to surgery" expandable metallic stent insertion for obstructive colorectal cancer: comparison with emergency operation. Dis Colon Rectum 46: S44-4.
35. Osman H (2000) The cost effectiveness of self-expanding metal stents in the management of malignant left-sided large bowel obstruction. Colorectal Dis 2: 233-237.
36. Karoui M, Charachon A, Delbaldo C, Loriau J, Laurent A, Sobhani I, Tran van Nhieu J, Delchier JC, Fagniez PL, Piedbois P, Cherqui D (2007) Stents for palliation of obstructive metastatic colon cancer: impact on management and chemotherapy administration. Arch Surg 142: 619-623; discussion 623.
37. Scheithauer W, Rosen H, Kornek GV, Sebesta C, Depisch D (1993) Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ 306: 752-755.